M&T Bank Corp grew its stake in shares of Metlife Inc (NYSE:MET) by 1.4% during the 4th quarter, HoldingsChannel reports. The fund owned 1,378,482 shares of the financial services provider’s stock after purchasing an additional 18,743 shares during the quarter. M&T Bank Corp’s holdings in Metlife were worth $69,695,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently bought and sold shares of the company. Sentry Investment Management LLC boosted its position in Metlife by 0.8% in the second quarter. Sentry Investment Management LLC now owns 82,321 shares of the financial services provider’s stock valued at $4,523,000 after buying an additional 690 shares during the last quarter. QS Investors LLC boosted its position in Metlife by 6.0% in the second quarter. QS Investors LLC now owns 17,337 shares of the financial services provider’s stock valued at $952,000 after buying an additional 988 shares during the last quarter. Cowen Prime Services LLC boosted its position in Metlife by 16.0% in the third quarter. Cowen Prime Services LLC now owns 7,250 shares of the financial services provider’s stock valued at $377,000 after buying an additional 1,000 shares during the last quarter. Xact Kapitalforvaltning AB boosted its position in Metlife by 0.7% in the third quarter. Xact Kapitalforvaltning AB now owns 152,710 shares of the financial services provider’s stock valued at $7,933,000 after buying an additional 1,004 shares during the last quarter. Finally, First National Trust Co. boosted its position in Metlife by 1.6% in the third quarter. First National Trust Co. now owns 63,661 shares of the financial services provider’s stock valued at $3,307,000 after buying an additional 1,019 shares during the last quarter. Hedge funds and other institutional investors own 76.36% of the company’s stock.

Shares of Metlife Inc (NYSE MET) opened at $44.28 on Friday. The company has a debt-to-equity ratio of 0.31, a current ratio of 0.16 and a quick ratio of 0.16. Metlife Inc has a 52-week low of $44.26 and a 52-week high of $55.91. The company has a market capitalization of $48,679.35, a P/E ratio of -88.56, a price-to-earnings-growth ratio of 1.03 and a beta of 1.31.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 13th. Shareholders of record on Monday, February 5th will be given a $0.40 dividend. The ex-dividend date of this dividend is Friday, February 2nd. This represents a $1.60 annualized dividend and a yield of 3.61%. Metlife’s dividend payout ratio is presently -320.00%.

A number of equities research analysts recently commented on MET shares. Goldman Sachs Group started coverage on Metlife in a research report on Wednesday, October 18th. They issued a “conviction-buy” rating and a $61.00 target price on the stock. ValuEngine lowered Metlife from a “strong-buy” rating to a “buy” rating in a research report on Thursday, November 9th. Zacks Investment Research lowered Metlife from a “hold” rating to a “sell” rating in a research report on Tuesday, January 2nd. Royal Bank of Canada reiterated an “outperform” rating and issued a $60.00 target price (up previously from $56.00) on shares of Metlife in a research report on Friday, November 3rd. Finally, Deutsche Bank started coverage on Metlife in a research report on Tuesday, January 2nd. They issued a “hold” rating and a $55.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, eleven have assigned a hold rating and nine have given a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus price target of $57.65.

TRADEMARK VIOLATION WARNING: This article was published by Daily Political and is owned by of Daily Political. If you are viewing this article on another domain, it was stolen and republished in violation of U.S. and international trademark & copyright law. The original version of this article can be viewed at https://www.dailypolitical.com/2018/02/09/metlife-inc-met-stake-boosted-by-mt-bank-corp.html.

Metlife Company Profile

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Metlife Inc (NYSE:MET).

Institutional Ownership by Quarter for Metlife (NYSE:MET)

Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.